Deler fremragende | 70,943,689 shares |
Insideraktier | 25.710.234 shares |
Insider ejerskab | 36,24 % |
Total Insiders | 30 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Phathom Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Steven L Basta President and CEO, Director - [D] [O] | 0 | 0 | |
Branning Todd P. | 0 | ||
Robert Charles Breedlove Principal Accounting Officer - [O] | 47.931 | 47.931 | |
Michael F Cola Director - [D] | 39.798 | 39.798 | |
Anne Marie Cook Chief Legal Off. & Corp. Sec. - [O] | 0 | 0 | |
Terrie Curran President and Chief Executive, Director - [D] [O] | 360.465 | 360.465 | |
Edwards Jonathan S. Director - [D] | 47.984 | 47.984 | |
Fhmls Ix, L.l.c.
10% Owner -
|
5.827.415 | 5.827.415 | |
Fhmls Ix, L.p.
10% Owner -
|
5.827.415 | 5.827.415 | |
Heidi Fields Director - [D] | 30.000 | 30.000 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Frazier Life Sciences IX, L.P.
10% Owner -
|
5.827.415 | 5.827.415 | |
Guzzo Anthony J. VP, Chief Accounting Officer - [O] | 8.399 | 8.399 | |
Molly Henderson CFO and CBO - [O] | 89.868 | 89.868 | |
Patrick J Heron
10% Owner -
|
5.827.415 | 5.827.415 | |
Frank Karbe Director - [D] | 67.500 | 67.500 | |
Aditya Kohli Chief Business Officer - [O] | 1.686.704 | 1.686.704 | |
Peter Kolchinsky
10% Owner -
|
3.115.008 | 3.115.008 | |
Ventures Management (Jersey) Ltd Medicxi
10% Owner -
|
61.975 | 61.975 | |
Azmi Nabulsi Chief Operating Officer - [O] | 1.101.869 | 1.101.869 | |
Asit Parikh Director - [D] | 113.500 | 113.500 |
Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
---|---|---|---|
Ra Capital Management, Llc
10% Owner -
|
3.115.008 | 3.115.008 | |
RA Capital Healthcare Fund LP
10% Owner -
|
3.115.008 | 3.115.008 | |
Theodore R Schroeder Director - [D] | 0 | 0 | |
Shah Rajeev M.
10% Owner -
|
3.115.008 | 3.115.008 | |
Slavinsky Christopher W. | 0 | ||
David A Socks Director - [D] | 19.500 | 19.500 | |
Mark Stenhouse Director - [D] | 30.000 | 30.000 | |
Pharmaceutical Co Ltd Takeda
10% Owner -
|
3.755.583 | 3.755.583 | |
James N Topper
Director, 10% Owner -
[D]
|
5.933.327 | 5.933.327 | |
Tadataka Yamada
Director, 10% Owner -
[D]
|
3.373.408 | 3.373.408 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PHAT / Phathom Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PHAT / Phathom Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-09 | 2025-09-05 | 4 | Breedlove Robert Charles | PHAT | Common Stock | D | 12,0900 | -461 | -6 | 47.931 | ||||
2025-07-18 | 2025-07-16 | 4 | Breedlove Robert Charles | PHAT | Common Stock | D | 8,3639 | -1.692 | -14 | 48.392 | ||||
2025-06-24 | 3 | Cook Anne Marie | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
2025-06-05 | 2025-06-03 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10.500 | 67.500 | ||||||
2025-06-05 | 2025-06-03 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 10.500 | 39.798 | ||||||
2025-06-05 | 2025-06-03 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 10.500 | 30.000 | ||||||
2025-06-05 | 2025-06-03 | 4 | Topper James N | PHAT | Common Stock | D | 10.500 | 42.596 | ||||||
2025-06-05 | 2025-06-03 | 4 | Parikh Asit | PHAT | Common Stock | D | 10.500 | 113.500 | ||||||
2025-06-05 | 2025-06-03 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 10.500 | 30.000 | ||||||
2025-05-23 | 2025-05-21 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,8649 | 3.780 | 15 | 59.403 | ||||
2025-05-15 | 2025-05-14 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,3205 | 6.300 | 21 | 55.623 | ||||
2025-05-15 | 2025-05-13 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,1637 | 1.120 | 4 | 49.323 | ||||
2025-05-13 | 2025-05-12 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,0395 | 12.601 | 38 | 48.203 | ||||
2025-05-13 | 2025-05-09 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,6177 | 2.226 | 8 | 35.602 | ||||
2025-05-13 | 2025-05-09 | 4 | Topper James N By Frazier Life Sciences X, L.P. | PHAT | Common Stock | I | 3,1928 | 33.376 | 107 | 33.376 | ||||
2025-05-08 | 2025-05-07 | 4 | Parikh Asit | PHAT | Common Stock | D | 2,3969 | 5.000 | 12 | 95.500 | ||||
2025-05-08 | 2025-05-06 | 4 | Parikh Asit | PHAT | Common Stock | D | 2,6000 | 5.000 | 13 | 90.500 | ||||
2025-05-06 | 3 | Breedlove Robert Charles | PHAT | Common Stock | D | 50.084 | ||||||||
2025-05-06 | 3 | Breedlove Robert Charles By 401(k) | PHAT | Common Stock | I | 5.108 | ||||||||
2025-04-16 | 2025-04-16 | 4 | Schroeder Theodore R | PHAT | Common Stock | D | 21.000 | 21.000 | ||||||
2025-04-16 | 3 | Schroeder Theodore R | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
2025-04-08 | 2025-04-07 | 4 | Henderson Molly | PHAT | Common Stock | D | 4,5513 | -3.678 | -17 | 89.868 | ||||
2025-04-03 | 3 | Basta Steven L | PHAT | No securities are beneficially owned. | D | 0 | ||||||||
2025-03-21 | 2024-09-10 | 4 | Parikh Asit | PHAT | Common Stock | D | 11,7200 | 7.500 | 88 | 93.000 | ||||
2025-03-17 | 2025-03-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 4,4200 | 10.000 | 44 | 85.500 | ||||
2025-03-03 | 2025-02-27 | 4 | Henderson Molly | PHAT | Common Stock | D | 72.000 | 165.546 | ||||||
2025-03-03 | 2025-02-27 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 79.200 | 312.590 | ||||||
2025-01-23 | 2025-01-21 | 4 | Henderson Molly | PHAT | Common Stock | D | 6,5883 | -6.583 | -43 | 93.546 | ||||
2025-01-23 | 2025-01-21 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 6,5885 | -7.886 | -52 | 233.390 | ||||
2025-01-23 | 2025-01-21 | 4 | Curran Terrie | PHAT | Common Stock | D | 6,5877 | -19.109 | -126 | 360.465 | ||||
2024-12-20 | 2024-12-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 8,0000 | -1.118 | -9 | 239.303 | ||||
2024-12-20 | 2024-12-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,0000 | -1.291 | -10 | 98.156 | ||||
2024-12-16 | 2024-12-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,1248 | 10.000 | 81 | 75.500 | ||||
2024-12-16 | 2024-12-13 | 4 | KARBE FRANK | PHAT | Common Stock | D | 7,9267 | 12.500 | 99 | 57.000 | ||||
2024-07-17 | 2024-07-15 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 11,7200 | -10.901 | -128 | 240.421 | ||||
2024-07-17 | 2024-07-15 | 4 | Henderson Molly | PHAT | Common Stock | D | 11,7200 | -4.325 | -51 | 99.447 | ||||
2024-07-17 | 2024-07-15 | 4 | Curran Terrie | PHAT | Common Stock | D | 11,7200 | -33.848 | -397 | 377.734 | ||||
2024-05-31 | 2024-05-31 | 4 | Henderson Molly | PHAT | Common Stoock | D | 7.500 | 102.763 | ||||||
2024-05-31 | 2024-05-31 | 4 | Nabulsi Azmi | PHAT | Common Stoock | D | 7.500 | 249.567 | ||||||
2024-05-31 | 2024-05-29 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10,1645 | 25.000 | 254 | 44.500 | ||||
2024-05-24 | 2024-05-23 | 4 | Topper James N | PHAT | Common Stock | D | 10.500 | 32.096 | ||||||
2024-05-24 | 2024-05-23 | 4 | Parikh Asit | PHAT | Common Stock | D | 10.500 | 65.500 | ||||||
2024-05-24 | 2024-05-23 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 10.500 | 29.298 | ||||||
2024-05-24 | 2024-05-23 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 10.500 | 19.500 | ||||||
2024-05-24 | 2024-05-23 | 4 | KARBE FRANK | PHAT | Common Stock | D | 10.500 | 19.500 | ||||||
2024-05-24 | 2024-05-23 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 10.500 | 19.500 | ||||||
2024-05-24 | 2024-05-23 | 4 | Socks David A | PHAT | Common Stock | D | 10.500 | 19.500 | ||||||
2024-04-10 | 2024-04-08 | 4 | Henderson Molly | PHAT | Common Stoock | D | 11,1000 | -3.435 | -38 | 95.263 | ||||
2024-03-26 | 2024-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 9,1100 | -16.851 | -154 | 410.784 | ||||
2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi IV LP | PHAT | Common Stock | I | 3.641.728 | ||||||||
2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Growth I LP | PHAT | Common Stock | I | 3.673.602 | ||||||||
2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Co-Invest IV LP | PHAT | Common Stock | I | 61.975 | ||||||||
2024-01-26 | 3 | Medicxi Ventures Management (Jersey) Ltd By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 87.267 | ||||||||
2024-01-25 | 2024-01-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 8,1000 | -3.703.703 | -30.000 | 3.755.583 | ||||
2024-01-22 | 2024-01-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,7533 | -6.307 | -49 | 98.698 | ||||
2023-11-21 | 2023-11-20 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,2415 | -2.127 | -15 | 103.061 | ||||
2023-11-08 | 2023-11-08 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,8000 | 2.500 | 20 | 55.000 | ||||
2023-11-08 | 2023-11-07 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,7600 | 4.000 | 31 | 52.500 | ||||
2023-11-08 | 2023-11-06 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,0400 | 1.000 | 8 | 48.500 | ||||
2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,9500 | -11.681 | -105 | 105.188 | ||||
2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,8000 | -811 | -6 | 116.869 | ||||
2023-11-03 | 2023-11-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 22.500 | 117.680 | ||||||
2023-11-03 | 2023-11-01 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 32.500 | 242.067 | ||||||
2023-11-03 | 2023-11-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 37.500 | 427.171 | ||||||
2023-07-21 | 2023-07-14 | 4/A | Henderson Molly | PHAT | Common Stock | D | 25.000 | 95.180 | ||||||
2023-07-17 | 2023-07-14 | 4 | Henderson Molly | PHAT | Common Stock | D | 1,0000 | 25.000 | 25 | 95.180 | ||||
2023-07-17 | 2023-07-14 | 4 | Curran Terrie | PHAT | Common Stock | D | 200.000 | 389.671 | ||||||
2023-07-17 | 2023-07-14 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 110.000 | 209.567 | ||||||
2023-06-05 | 2023-06-02 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,4000 | 15.000 | 111 | 47.500 | ||||
2023-06-05 | 2023-06-02 | 4 | Henderson Molly | PHAT | Common Stock | D | 11,4121 | -1.960 | -22 | 68.506 | ||||
2023-05-30 | 2023-05-25 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 9.000 | 18.798 | ||||||
2023-05-30 | 2023-05-25 | 4 | Stenhouse Mark | PHAT | Common Stock | D | 9.000 | 9.000 | ||||||
2023-05-30 | 2023-05-25 | 4 | Socks David A | PHAT | Common Stock | D | 9.000 | 9.000 | ||||||
2023-05-30 | 2023-05-25 | 4 | Parikh Asit | PHAT | Common Stock | D | 9.000 | 32.500 | ||||||
2023-05-30 | 2023-05-25 | 4 | FIELDS HEIDI | PHAT | Common Stock | D | 9.000 | 9.000 | ||||||
2023-05-30 | 2023-05-25 | 4 | KARBE FRANK | PHAT | Common Stock | D | 9.000 | 9.000 | ||||||
2023-05-30 | 2023-05-25 | 4 | Topper James N | PHAT | Common Stock | D | 9.000 | 21.596 | ||||||
2023-05-23 | 2023-05-22 | 4 | Henderson Molly | PHAT | Common Stock | D | 12,8744 | -2.110 | -27 | 70.466 | ||||
2023-04-11 | 2023-04-11 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 8,2600 | 10.000 | 83 | 99.567 | ||||
2023-04-11 | 2023-04-10 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,5500 | 1.000 | 8 | 23.500 | ||||
2023-04-07 | 2023-04-06 | 4 | Curran Terrie | PHAT | Common Stock | D | 7,8199 | 12.919 | 101 | 188.290 | ||||
2023-04-07 | 2023-04-06 | 4 | Henderson Molly | PHAT | Common Stock | D | 7,2700 | -3.439 | -25 | 72.576 | ||||
2023-03-03 | 2023-03-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 8,5309 | -2.032 | -17 | 76.015 | ||||
2023-03-03 | 2023-03-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 8,5411 | -1.436 | -12 | 175.371 | ||||
2023-02-14 | 2023-02-13 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,7320 | 5.000 | 39 | 22.500 | ||||
2023-01-20 | 2023-01-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 45.000 | 89.567 | ||||||
2023-01-20 | 2023-01-20 | 4 | Curran Terrie | PHAT | Common Stock | D | 8,1995 | -5.821 | -48 | 176.807 | ||||
2023-01-20 | 2023-01-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 97.500 | 182.628 | ||||||
2023-01-20 | 2023-01-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 33.000 | 78.047 | ||||||
2023-01-12 | 2023-01-12 | 4 | Parikh Asit | PHAT | Common Stock | D | 7,0000 | 5.000 | 35 | 17.500 | ||||
2022-11-23 | 2022-11-21 | 4 | Curran Terrie | PHAT | Common Stock | D | 9,6000 | -1.526 | -15 | 83.720 | ||||
2022-11-23 | 2022-11-21 | 4 | Henderson Molly | PHAT | Common Stock | D | 9,6000 | -2.159 | -21 | 43.341 | ||||
2022-09-02 | 2022-09-01 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 7.500 | 41.971 | ||||||
2022-09-02 | 2022-09-01 | 4 | Henderson Molly | PHAT | Common Stock | D | 7.500 | 45.500 | ||||||
2022-09-02 | 2022-09-01 | 4 | Curran Terrie | PHAT | Common Stock | D | 7.500 | 85.246 | ||||||
2022-05-27 | 2022-05-25 | 4 | COLA MICHAEL F | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15.000 | 15.000 | |||||
2022-05-27 | 2022-05-25 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15.000 | 15.000 | |||||
2022-05-27 | 2022-05-25 | 4 | FIELDS HEIDI | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15.000 | 15.000 | |||||
2022-05-27 | 2022-05-25 | 4 | Socks David A | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15.000 | 15.000 | |||||
2022-05-27 | 2022-05-25 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 7,40 | 15.000 | 15.000 | |||||
2022-05-27 | 2022-05-25 | 4 | KARBE FRANK | PHAT | Stock Option (Right to Buy) | D | 7,40 | 10.000 | 10.000 | |||||
2022-05-20 | 2022-05-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 12.000 | 33.378 | ||||||
2022-05-20 | 2022-05-19 | 4 | Henderson Molly | PHAT | Common Stock | D | 12.000 | 38.000 | ||||||
2022-05-20 | 2022-05-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 12.000 | 76.595 | ||||||
2022-05-16 | 2022-05-16 | 4 | Nabulsi Azmi by Trust | PHAT | Common Stock | I | 8,1644 | 20.000 | 163 | 785.700 | ||||
2022-05-16 | 2022-05-13 | 4 | Curran Terrie | PHAT | Common Stock | D | 7,4066 | 20.500 | 152 | 64.595 | ||||
2022-05-16 | 2022-05-13 | 4 | Henderson Molly | PHAT | Common Stock | D | 6.000 | 26.000 | ||||||
2022-05-16 | 2022-05-12 | 4 | Parikh Asit | PHAT | Common Stock | D | 8,0000 | 12.500 | 100 | 12.500 | ||||
2022-04-26 | 2022-04-25 | 4 | KARBE FRANK | PHAT | Stock Option (Right to Buy) | D | 13,61 | 20.000 | 20.000 | |||||
2022-04-06 | 2022-04-05 | 4 | Henderson Molly | PHAT | Stock Option (Right to Buy) | D | 15,08 | 100.000 | 100.000 | |||||
2022-04-06 | 2022-04-05 | 4 | Henderson Molly | PHAT | Common Stock | D | 20.000 | 20.000 | ||||||
2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Warrants | D | 0,00 | -7.359.304 | 0 | |||||
2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 19,0000 | -18 | -0 | 7.459.286 | ||||
2022-03-16 | 2022-03-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 7.359.304 | 7.459.304 | ||||||
2022-02-18 | 2019-10-29 | 4 | COLA MICHAEL F | PHAT | Common Stock | D | 19,0000 | 9.798 | 186 | 9.798 | ||||
2022-01-21 | 2022-01-19 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 15,21 | 97.500 | 97.500 | |||||
2022-01-21 | 2022-01-19 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | 19.500 | 21.378 | ||||||
2022-01-21 | 2022-01-19 | 4 | Guzzo Anthony J. | PHAT | Stock Option (Right to Buy) | D | 15,21 | 30.000 | 30.000 | |||||
2022-01-21 | 2022-01-19 | 4 | Guzzo Anthony J. | PHAT | Common Stock | D | 6.000 | 8.399 | ||||||
2022-01-21 | 2022-01-19 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 15,21 | 206.250 | 206.250 | |||||
2022-01-21 | 2022-01-19 | 4 | Curran Terrie | PHAT | Common Stock | D | 41.250 | 44.095 | ||||||
2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Warrants | D | 0,00 | -228.696 | 7.359.304 | |||||
2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 20,8500 | -1.000.000 | -20.850 | 100.000 | ||||
2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 19,0000 | -1 | -0 | 1.100.000 | ||||
2021-11-08 | 2021-11-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 228.696 | 1.100.001 | ||||||
2021-10-08 | 2021-10-08 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,0490 | -2.529 | -81 | 1.211.346 | ||||
2021-10-08 | 2021-10-07 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,6639 | -15.471 | -505 | 1.213.875 | ||||
2021-09-23 | 2021-09-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,0600 | -4.100 | -131 | 1.229.346 | ||||
2021-09-23 | 2021-09-21 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,3058 | -324 | -11 | 1.233.446 | ||||
2021-09-23 | 2021-09-21 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,7868 | -13.576 | -445 | 1.233.770 | ||||
2021-08-18 | 2021-08-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 31,4907 | -13.791 | -434 | 1.247.346 | ||||
2021-08-18 | 2021-08-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 30,4704 | -4.209 | -128 | 1.261.137 | ||||
2021-07-14 | 2021-07-13 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 34,05 | 7.500 | 7.500 | |||||
2021-07-09 | 2021-07-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0500 | -2.609 | -91 | 871.305 | ||||
2021-07-06 | 2021-07-02 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0100 | -100 | -4 | 873.914 | ||||
2021-07-06 | 2021-07-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1600 | -8.226 | -289 | 874.014 | ||||
2021-06-29 | 2021-06-29 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,0012 | -13.960 | -475 | 1.260.945 | ||||
2021-06-29 | 2021-06-28 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,0869 | -156 | -5 | 1.274.905 | ||||
2021-06-29 | 2021-06-28 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,0678 | -25.884 | -882 | 1.275.061 | ||||
2021-06-29 | 2021-06-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0800 | -370 | -13 | 882.240 | ||||
2021-06-29 | 2021-06-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,0700 | -1.250 | -45 | 882.610 | ||||
2021-06-29 | 2021-06-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,4600 | -22.881 | -811 | 883.860 | ||||
2021-06-25 | 2021-06-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | -10.848 | -381 | 906.741 | ||||
2021-06-25 | 2021-06-23 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | -200 | -7 | 917.589 | ||||
2021-06-23 | 2021-06-22 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | -100 | -4 | 917.789 | ||||
2021-06-23 | 2021-06-21 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3100 | -9.294 | -328 | 917.889 | ||||
2021-06-21 | 2021-06-18 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1300 | -5.398 | -190 | 927.183 | ||||
2021-06-21 | 2021-06-17 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0800 | -3.305 | -116 | 932.581 | ||||
2021-06-16 | 2021-06-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0600 | -2.826 | -99 | 935.886 | ||||
2021-06-11 | 3 | Guzzo Anthony J. | PHAT | Common Stock | D | 804 | ||||||||
2021-06-11 | 2021-06-10 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | -2.102 | -74 | 938.712 | ||||
2021-06-11 | 2021-06-09 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,2800 | -1.191 | -42 | 940.814 | ||||
2021-06-09 | 2021-06-08 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | -100 | -4 | 942.005 | ||||
2021-06-09 | 2021-06-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0500 | -2.264 | -79 | 942.105 | ||||
2021-06-04 | 2021-06-02 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1800 | -4.300 | -151 | 944.369 | ||||
2021-06-02 | 2021-06-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,2000 | -3.967 | -144 | 948.669 | ||||
2021-06-02 | 2021-06-01 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5500 | -7.244 | -258 | 952.636 | ||||
2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,5500 | -2.104 | -79 | 959.880 | ||||
2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,4000 | -2.668 | -97 | 961.984 | ||||
2021-06-02 | 2021-05-28 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3700 | -4.133 | -146 | 964.652 | ||||
2021-05-28 | 2021-05-27 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,5500 | -2.279 | -86 | 968.785 | ||||
2021-05-28 | 2021-05-27 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,9900 | -6.174 | -228 | 971.064 | ||||
2021-05-28 | 2021-05-26 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,9200 | -4.889 | -181 | 977.238 | ||||
2021-05-28 | 2021-05-26 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,4500 | -7.469 | -272 | 982.127 | ||||
2021-05-26 | 2021-05-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,5900 | -548 | -20 | 989.596 | ||||
2021-05-26 | 2021-05-25 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,1600 | -10.399 | -376 | 990.144 | ||||
2021-05-26 | 2021-05-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,1000 | -1.683 | -61 | 1.000.543 | ||||
2021-05-26 | 2021-05-24 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5800 | -8.911 | -317 | 1.002.226 | ||||
2021-05-24 | 2021-05-21 | 4 | Yamada Tadataka | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12.500 | 12.500 | |||||
2021-05-24 | 2021-05-21 | 4 | Socks David A | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12.500 | 12.500 | |||||
2021-05-24 | 2021-05-21 | 4 | COLA MICHAEL F | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12.500 | 12.500 | |||||
2021-05-24 | 2021-05-21 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12.500 | 12.500 | |||||
2021-05-24 | 2021-05-21 | 4 | Parikh Asit | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12.500 | 12.500 | |||||
2021-05-24 | 2021-05-21 | 4 | FIELDS HEIDI | PHAT | Stock Option (Right to Buy) | D | 35,49 | 12.500 | 12.500 | |||||
2021-05-24 | 2021-05-21 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,7400 | -11.648 | -416 | 1.011.137 | ||||
2021-05-24 | 2021-05-20 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1000 | -7.098 | -249 | 1.022.785 | ||||
2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,2662 | -305 | -11 | 1.300.945 | ||||
2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9340 | -2.278 | -80 | 1.301.250 | ||||
2021-05-21 | 2021-05-20 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,7606 | -899 | -30 | 1.303.528 | ||||
2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 33,3796 | -3.229 | -108 | 1.304.427 | ||||
2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 32,7836 | -16.020 | -525 | 1.307.656 | ||||
2021-05-21 | 2021-05-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 31,9557 | -17.269 | -552 | 1.323.676 | ||||
2021-05-18 | 2021-05-14 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0000 | -100 | -4 | 1.029.883 | ||||
2021-05-14 | 2021-05-13 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3300 | -100 | -4 | 1.029.983 | ||||
2021-05-14 | 2021-05-12 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,0600 | -905 | -33 | 1.030.083 | ||||
2021-05-14 | 2021-05-12 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,3900 | -10.871 | -385 | 1.030.988 | ||||
2021-05-11 | 2021-05-07 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0300 | -1.011 | -35 | 1.041.859 | ||||
2021-05-07 | 2021-05-06 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,0100 | -202 | -7 | 1.042.870 | ||||
2021-05-07 | 2021-05-05 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,1400 | -6.936 | -244 | 1.043.072 | ||||
2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 38,5300 | -100 | -4 | 1.050.008 | ||||
2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,4700 | -3.500 | -131 | 1.050.108 | ||||
2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 36,2100 | -4.690 | -170 | 1.053.608 | ||||
2021-05-05 | 2021-05-04 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 35,5000 | -11.070 | -393 | 1.058.298 | ||||
2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 39,0600 | -203 | -8 | 1.069.368 | ||||
2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 38,4500 | -11.272 | -433 | 1.069.571 | ||||
2021-05-05 | 2021-05-03 | 4 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 37,6000 | -3.157 | -119 | 1.080.843 | ||||
2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,8609 | -1.089 | -41 | 765.700 | ||||
2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,0866 | -1.400 | -52 | 766.789 | ||||
2021-05-04 | 2021-05-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,1535 | -1.968 | -71 | 768.189 | ||||
2021-05-04 | 2021-05-03 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,5876 | -5.753 | -222 | 770.157 | ||||
2021-05-04 | 2021-05-03 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,8461 | -4.290 | -162 | 775.910 | ||||
2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 38,0302 | -6.795 | -258 | 1.340.945 | ||||
2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 37,3738 | -6.328 | -237 | 1.347.740 | ||||
2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,9698 | -3.359 | -121 | 1.354.068 | ||||
2021-04-07 | 2021-04-06 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9605 | -1.400 | -49 | 1.357.427 | ||||
2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 37,1532 | -1.730 | -64 | 1.358.827 | ||||
2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 36,4002 | -7.769 | -283 | 1.360.557 | ||||
2021-04-07 | 2021-04-05 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,6872 | -12.619 | -450 | 1.368.326 | ||||
2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,1131 | -785 | -29 | 780.200 | ||||
2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,3656 | -4.316 | -157 | 780.985 | ||||
2021-04-05 | 2021-04-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 35,6645 | -4.252 | -152 | 785.301 | ||||
2021-04-05 | 2021-04-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,1411 | -1.742 | -66 | 789.553 | ||||
2021-04-05 | 2021-04-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 37,2766 | -3.405 | -127 | 791.295 | ||||
2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 6,95 | -11.513 | 855.687 | |||||
2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 44,0838 | -1.140 | -50 | 0 | ||||
2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 43,2368 | -10.373 | -448 | 1.140 | ||||
2021-03-23 | 2021-03-22 | 4 | Curran Terrie | PHAT | Common Stock | D | 6,9500 | 11.513 | 80 | 11.513 | ||||
2021-03-15 | 2021-03-11 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 43,7500 | -710.000 | -31.062 | 3.115.008 | ||||
2021-03-12 | 2021-03-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,6700 | -500 | -23 | 1.380.945 | ||||
2021-03-12 | 2021-03-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,5367 | -731 | -35 | 1.381.445 | ||||
2021-03-12 | 2021-03-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,1809 | -41.698 | -1.967 | 1.382.176 | ||||
2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 49,9303 | -1.802 | -90 | 1.423.874 | ||||
2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 49,0203 | -7.844 | -385 | 1.425.676 | ||||
2021-03-12 | 2021-03-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,3163 | -2.425 | -117 | 1.433.520 | ||||
2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,2293 | -2.070 | -96 | 794.700 | ||||
2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,1722 | -1.600 | -72 | 796.770 | ||||
2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,7300 | -24 | -1 | 798.370 | ||||
2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,1576 | -4.833 | -223 | 798.394 | ||||
2021-03-03 | 2021-03-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 44,5950 | -600 | -27 | 803.227 | ||||
2021-03-03 | 2021-03-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 46,0549 | -1.548 | -71 | 803.827 | ||||
2021-03-03 | 2021-03-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,7696 | -3.825 | -175 | 805.375 | ||||
2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 44,6967 | -2.084 | -93 | 1.435.945 | ||||
2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 43,3461 | -1.881 | -82 | 1.438.029 | ||||
2021-02-23 | 2021-02-23 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,5018 | -1.019 | -43 | 1.439.910 | ||||
2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,9901 | -1.417 | -67 | 1.440.929 | ||||
2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,0250 | -7.241 | -333 | 1.442.346 | ||||
2021-02-23 | 2021-02-22 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 45,2652 | -11.482 | -520 | 1.449.587 | ||||
2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,6100 | -18.316 | -872 | 1.461.069 | ||||
2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,0834 | -21.360 | -1.006 | 1.479.385 | ||||
2021-02-23 | 2021-02-19 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,0207 | -5.200 | -239 | 1.500.745 | ||||
2021-02-12 | 2020-12-01 | 5 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | -27.000 | 1.505.945 | ||||||
2021-02-03 | 2021-02-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 41,1626 | -6.384 | -263 | 809.200 | ||||
2021-02-03 | 2021-02-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 40,5087 | -2.700 | -109 | 815.584 | ||||
2021-02-03 | 2021-02-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 38,0881 | -5.416 | -206 | 818.284 | ||||
2021-01-29 | 2021-01-28 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 39,11 | 150.000 | 150.000 | |||||
2021-01-29 | 2021-01-28 | 4 | Branning Todd P. | PHAT | Stock Option (Right to Buy) | D | 39,11 | 60.000 | 60.000 | |||||
2021-01-29 | 2021-01-28 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 39,11 | 225.000 | 225.000 | |||||
2021-01-13 | 2021-01-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 36,1845 | -20.091 | -727 | 1.532.945 | ||||
2021-01-13 | 2021-01-12 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 35,7382 | -7.074 | -253 | 1.553.036 | ||||
2021-01-13 | 2021-01-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 34,9235 | -12.835 | -448 | 1.560.110 | ||||
2021-01-05 | 2020-01-05 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,7694 | -1.854 | -63 | 823.700 | ||||
2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 34,5700 | -100 | -3 | 825.554 | ||||
2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,9332 | -7.614 | -258 | 825.654 | ||||
2021-01-05 | 2020-01-04 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 33,0174 | -4.932 | -163 | 833.268 | ||||
2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,0000 | -100 | -4 | 1.572.945 | ||||
2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,4302 | -12.915 | -535 | 1.573.045 | ||||
2020-12-18 | 2020-12-17 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 40,4894 | -35.197 | -1.425 | 1.585.960 | ||||
2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,9900 | -200 | -10 | 1.621.157 | ||||
2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 48,1900 | -12.954 | -624 | 1.621.357 | ||||
2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 47,3492 | -13.292 | -629 | 1.634.311 | ||||
2020-12-18 | 2020-12-16 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 46,2205 | -5.000 | -231 | 1.647.603 | ||||
2020-12-03 | 2020-12-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,5700 | -2.995 | -136 | 838.200 | ||||
2020-12-03 | 2020-12-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 45,0500 | -4.307 | -194 | 841.195 | ||||
2020-12-03 | 2020-12-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 44,8300 | -1.828 | -82 | 845.502 | ||||
2020-12-03 | 2020-12-01 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 43,9900 | -5.370 | -236 | 847.330 | ||||
2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 40,3605 | -903 | -36 | 1.652.603 | ||||
2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 39,2240 | -3.354 | -132 | 1.653.506 | ||||
2020-11-12 | 2020-11-11 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 38,1747 | -2.620 | -100 | 1.656.860 | ||||
2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 43,0700 | -200 | -9 | 1.659.480 | ||||
2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,3114 | -4.601 | -195 | 1.664.081 | ||||
2020-11-12 | 2020-11-10 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,2923 | -7.880 | -325 | 1.668.682 | ||||
2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 44,0000 | -100 | -4 | 1.676.562 | ||||
2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 42,6663 | -5.477 | -234 | 1.676.662 | ||||
2020-11-12 | 2020-11-09 | 4 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 41,9478 | -5.207 | -218 | 1.682.139 | ||||
2020-11-03 | 2020-11-02 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 36,8294 | -14.500 | -534 | 852.700 | ||||
2020-11-03 | 2020-06-25 | 4 | Nabulsi Azmi By Trust | PHAT | Common Stock | I | 867.200 | 867.200 | ||||||
2020-11-03 | 2020-06-25 | 4 | Nabulsi Azmi | PHAT | Common Stock | D | -867.200 | 0 | ||||||
2020-07-13 | 2020-07-13 | 4 | Branning Todd P. | PHAT | Stock Option (Right to Buy) | D | 29,43 | 85.000 | 85.000 | |||||
2020-07-02 | 2020-07-01 | 4 | Curran Terrie | PHAT | Stock Option (Right to Buy) | D | 32,20 | 175.000 | 175.000 | |||||
2020-07-02 | 2020-07-01 | 4 | Nabulsi Azmi | PHAT | Stock Option (Right to Buy) | D | 32,20 | 70.000 | 70.000 | |||||
2020-06-16 | 2020-06-12 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | -1.456.854 | 5.827.415 | ||||||
2020-05-22 | 2020-05-21 | 4 | FIELDS HEIDI | PHAT | Stock Options | D | 36,85 | 10.000 | 10.000 | |||||
2020-05-22 | 2020-05-21 | 4 | Topper James N | PHAT | Stock Option | D | 36,85 | 10.000 | 10.000 | |||||
2020-05-22 | 2020-05-21 | 4 | Yamada Tadataka | PHAT | Stock Option | D | 36,85 | 10.000 | 10.000 | |||||
2020-05-22 | 2020-05-21 | 4 | COLA MICHAEL F | PHAT | Stock Option | D | 36,85 | 10.000 | 10.000 | |||||
2020-04-03 | 2020-04-01 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,8609 | 117.600 | 2.924 | 3.825.008 | ||||
2020-03-31 | 2020-03-31 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,5511 | 30.600 | 751 | 3.707.408 | ||||
2020-03-31 | 2020-03-27 | 4 | RA CAPITAL MANAGEMENT, LLC | PHAT | Common Stock | I | 24,6000 | 30.000 | 738 | 3.676.808 | ||||
2020-03-19 | 2020-03-17 | 4 | Stenhouse Mark | PHAT | Stock Option (Right to Buy) | D | 29,84 | 20.000 | 20.000 | |||||
2020-02-06 | 3/A | Shah Rajeev M. | PHAT | Common Stock | I | 3.646.808 | ||||||||
2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7.293.292 | ||||||||
2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7.293.292 | ||||||||
2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7.293.292 | ||||||||
2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7.293.292 | ||||||||
2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7.293.292 | ||||||||
2019-11-04 | 3 | Shah Rajeev M. | PHAT | Common Stock | I | 7.293.292 | ||||||||
2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Convertible Promissory Notes | D | 0 | |||||||
2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | 19,0000 | 1.052.631 | 20.000 | 7.284.269 | ||||
2019-10-30 | 2019-10-29 | 4 | Frazier Life Sciences IX, L.P. | PHAT | Common Stock | D | 15,2000 | 1.353.640 | 20.575 | 6.231.638 | ||||
2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Convertible Promissory Notes | I | 15,20 | 0 | ||||||
2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Convertible Promissory Notes | I | 15,20 | 0 | ||||||
2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 19,0000 | 24.426 | 464 | 47.984 | ||||
2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Common Stock | I | 19,0000 | 1.028.205 | 19.536 | 2.019.877 | ||||
2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth Co-Invest I LP | PHAT | Common Stock | I | 15,2000 | 23.558 | 358 | 23.558 | ||||
2019-10-30 | 2019-10-29 | 4 | Edwards Jonathan S. By Medicxi Growth I LP | PHAT | Common Stock | I | 15,2000 | 991.672 | 15.073 | 991.672 | ||||
2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9.755.996 | ||||||||
2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9.755.996 | ||||||||
2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9.755.996 | ||||||||
2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9.755.996 | ||||||||
2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9.755.996 | ||||||||
2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9.755.996 | ||||||||
2019-10-24 | 3 | Heron Patrick J | PHAT | Common Stock | D | 9.755.996 | ||||||||
2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1.734.400 | ||||||||
2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1.734.400 | ||||||||
2019-10-24 | 3 | Nabulsi Azmi | PHAT | Common Stock | D | 1.734.400 | ||||||||
2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3.373.408 | ||||||||
2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3.373.408 | ||||||||
2019-10-24 | 3 | Socks David A David A. Socks 2013 Revocable Trust | PHAT | Common Stock | I | 3.373.408 | ||||||||
2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2.168.000 | ||||||||
2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2.168.000 | ||||||||
2019-10-24 | 3 | TAKEDA PHARMACEUTICAL CO LTD | PHAT | Common Stock | D | 2.168.000 | ||||||||
2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3.373.408 | ||||||||
2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3.373.408 | ||||||||
2019-10-24 | 3 | Yamada Tadataka | PHAT | Common Stock | D | 3.373.408 | ||||||||
2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1.686.704 | ||||||||
2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1.686.704 | ||||||||
2019-10-24 | 3 | Kohli Aditya | PHAT | Common Stock | D | 1.686.704 |